Method and Apparatus for Using Iodinated Polymer as an Antimicrobial Agent to Manage the Suppression and Disinfection of Pathogens

A method of providing polyiodide resin powder-enhanced personal protective equipment (PPE) capable of creating a protective barrier around the PPE for a direct contact kill of bacteria, fungi and viruses, the method comprising the steps of:

• reacting a cationic resin having a positive charge and an anion having a negative charge in the presence of iodine (I2 as a mineral) and Iodide (I−) salt (sodium or potassium iodide) to allow for the formation of I3−, I5−, and I7− thereby forming a polyiodide resin having a total weight of iodine ranging from about 45% to about 70% by weight of polyiodide complex depending on the introduction of I3−, I5−, and/or I7−;
• processing said polyiodide resin to form a polyiodide resin powder having a mesh size of about 1 μm to about 150 μm;
• and
• introducing said polyiodide resin powder into an extrusion process as a feedstock to be direct spun to form a fiber textile product comprising up to about 10% by weight of added polymer that is capable of being used to create a polyiodide resin-enhanced PPE apparatus that enables sub-microscopic protection between the apparatus and a user.

A method of preparing a topical treatment for wound care or preventative applications, the method comprising the steps of:

• reacting a cationic resin having a positive charge and an anion having a negative charge in the presence of iodine (I2 as a mineral) and Iodide (I−) salt (sodium or potassium iodide) to allow for the formation of I3−, I5−, and I7− thereby forming a polyiodide resin having a total weight of iodine ranging from about 45% to about 70% by weight of polyiodide complex depending on the introduction of I3−, I5−, and/or I7−;
• processing said polyiodide resin to form a polyiodide resin powder having a mesh size of about 1 μm to about 150 μm;
• and
• dissolving a carbomer in an aqueous solution for a specified period of time;
• and
• mixing said carbomer solution with said polyiodide resin powder to form create a polyiodide resin-enhanced topical agent comprising up to about 10% by weight of added polymer and capable of being used on a patient.